DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Macha S, Rose P, Mattheus M. et al.
Pharmacokinetics, safety and tolerability of empagliflozin, a sodium glucose
cotransporter 2 inhibitor, in patients with hepatic impairment.
Diabetes Obes Metab 2014;
16: 118-123
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.